Vijaya Raj Bhatt
Overview
Explore the profile of Vijaya Raj Bhatt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
169
Citations
1598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munshi P, Olin R, Wall S, McCurdy S, Al-Juhaishi T, Baker J, et al.
Transplant Cell Ther
. 2025 Feb;
PMID: 39961473
Geriatric assessment (GA) may identify vulnerabilities and promote risk-stratification in older adults predisposed to toxicities after autologous (auto), allogeneic (allo) hematopoietic cell transplantation (HCT) and chimeric antigen T-cell therapies (CAR...
2.
Dhakal P, Wichman C, Pozehl B, Elnair R, Yellala A, Mahato K, et al.
Res Sq
. 2025 Jan;
PMID: 39866883
Background: Patients' preferences are crucial to formulating personalized treatment plans. We developed a self-reported questionnaire, Therapy Preference Scale (TPS), to examine treatment preferences of patients with cancer. Methods: TPS has...
3.
Davids M, Brander D, Alvarado Valero Y, Alvarado-Valero Y, Diefenbach C, Diefenbach C, et al.
Blood Adv
. 2024 Dec;
9(4):820-832.
PMID: 39705540
The antiapoptotic protein, myeloid cell leukemia-1 (Mcl-1), contributes to the pathophysiology of acute myeloid leukemia (AML) and certain B-cell malignancies. Tumor dependence on Mcl-1 is associated with resistance to venetoclax....
4.
Bhatt V
Curr Oncol Rep
. 2024 Sep;
26(11):1349-1354.
PMID: 39259399
Purpose Of Review: To highlight the priorities in geriatric assessment research in myeloid malignancies and discuss design considerations necessary to ensure research is patient-centric, generalizeable, and high quality. Recent Findings:...
5.
Bhatt V, Shostrom V, Choe H, Hamilton B, Gundabolu K, Maness L, et al.
J Clin Oncol
. 2024 Aug;
42(33):3977-3985.
PMID: 39151112
Purpose: Sclerotic chronic graft-versus-host disease (cGVHD) represents a highly morbid and refractory form of cGVHD, and novel therapies for sclerotic cGVHD are critically needed. This study aimed to determine the...
6.
Jain T, Estrada-Merly N, Salas M, Kim S, DeVos J, Chen M, et al.
Blood Adv
. 2024 Jun;
8(16):4281-4293.
PMID: 38916866
We evaluate the impact of donor types on outcomes of hematopoietic cell transplantation (HCT) in myelofibrosis, using the Center for International Blood and Marrow Transplant Research registry data for HCTs...
7.
Sureda A, Carpenter P, Bacigalupo A, Bhatt V, de la Fuente J, Ho A, et al.
Bone Marrow Transplant
. 2024 Jun;
59(9):1335.
PMID: 38907026
No abstract available.
8.
Adhikari B, Shrestha N, Bhatt V
J Cancer Surviv
. 2024 May;
PMID: 38795285
Purpose: Up to 40% patients with cancer reporting pain may not receive optimal analgesia indicating inadequate treatment of pain. We examined the patterns of outpatient pain management in patients with...
9.
Farhadfar N, Rashid N, Chen K, DeVos J, Wang T, Ballen K, et al.
Blood Adv
. 2024 May;
8(18):4963-4976.
PMID: 38776400
Socioeconomic status (SES) and race/ethnicity have been associated with the outcomes of allogeneic hematopoietic stem cell transplantation (allo-HCT). Certain aspects of graft-versus-host disease (GVHD) management, such as the need for...
10.